Circio Holding ASA (OSL:CRNA) Enterprise Value: kr2,016.72 Mil (As of Jul. 11, 2026) ***


OSL:CRNA Circio Holding ASA OSL:CRNA
26 GF Score
Price kr7.34
! 3 Warning Signs
View Full Analysis

What is Circio Holding ASA Enterprise Value?

Circio Holding ASA OSL:CRNA -0.27% 26 Enterprise Value is kr2,016.72 Mil as of Jul. 11, 2026. GuruFocus rates OSL:CRNA with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Circio Holding ASA's Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.74 Mil. Therefore, Circio Holding ASA's EV-to-EBIT ratio for today is -44.09.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Circio Holding ASA's Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.71 Mil. Therefore, Circio Holding ASA's EV-to-EBITDA ratio for today is -44.12.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Circio Holding ASA's Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil. Therefore, Circio Holding ASA's EV-to-Revenue ratio for today is .

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Circio Holding ASA's Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.82 Mil. Therefore, Circio Holding ASA's EV-to-OCF ratio for today is -44.01.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Circio Holding ASA's Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.82 Mil. Therefore, Circio Holding ASA's EV-to-FCF ratio for today is -44.01.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Circio Holding ASA  (OSL:CRNA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Circio Holding ASA's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2016.719/-45.738
=-44.09

Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Circio Holding ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.74 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Circio Holding ASA's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2016.719/-45.713
=-44.12

Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Circio Holding ASA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.71 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Circio Holding ASA's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2016.719/0
=

Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Circio Holding ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Circio Holding ASA's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=2016.719/-45.824
=-44.01

Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Circio Holding ASA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.82 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Circio Holding ASA's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2016.719/-45.824
=-44.01

Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Circio Holding ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-45.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Circio Holding ASA Enterprise Value Related Terms


Circio Holding ASA Enterprise Value Historical Data

* Premium members only.

The historical data trend for Circio Holding ASA's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA Enterprise Value Chart

Circio Holding ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 297.79 207.01 142.35 48.95 169.50

Circio Holding ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 142.35 58.61 48.95 73.13 169.50

OSL:CRNA vs VRTX, REGN, ALNY: Enterprise Value Comparison

For the Biotechnology subindustry, Circio Holding ASA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circio Holding ASA Enterprise Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Enterprise Value falls into.


OSL:CRNA
26GF Score
Circio Holding ASA OSL:CRNA
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Circio Holding ASA Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Circio Holding ASA's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Circio Holding ASA's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of kr2,016.72 Mil mean?
Circio Holding ASA (OSL:CRNA) has a Enterprise Value of kr2,016.72 Mil as of Jul. 11, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Circio Holding ASA and its competitors.
Is Circio Holding ASA's Enterprise Value too high?
Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil. Overall, Circio Holding ASA has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Circio Holding ASA's Enterprise Value compare to VRTX and REGN?
Circio Holding ASA's Enterprise Value of kr2,016.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Circio Holding ASA and its competitors. Circio Holding ASA's current Enterprise Value is kr2,016.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Circio Holding ASA stock overvalued right now?
Circio Holding ASA (OSL:CRNA) has a current Enterprise Value of kr2,016.72 Mil. The current Enterprise Value is kr2,016.72 Mil. Circio Holding ASA's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Circio Holding ASA (OSL:CRNA), the current Enterprise Value is kr2,016.72 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Circio Holding ASA Business Description

Other Exchanges 0RIS:UKTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
26GF Score

Get the complete analysis for OSL:CRNA

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr7.34
Price